Found 7 results
Filters: Author is M. McMahon  [Clear All Filters]
Morgan SG, Kennedy J, Boothe K, McMahon M, Roughead E, Watson D. Toward an understanding of high performance pharmaceutical policy systems: a ‘triple-A’ framework and example analysis. The Open Health and Policy Journal. 2009;2:1-9.
Morgan SG, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. Health policy (Amsterdam, Netherlands)Health Policy. 2008;87(2):133-145.
Morgan SG, Hanley G, McMahon M, Barer ML. Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand. Healthcare policy = Politiques de santeHealthc.Policy.. 2007;3(1):e121-40.
Morgan SG, McMahon M, Mitton C. Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Applied health economics and health policyAppl.Health.Econ.Health.Policy.. 2006;5(2):67-73.
Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Health affairs (Project Hope)Health.Aff.(Millwood). 2006;25(2):337-347.
McMahon M, Morgan SG, Mitton C. The Common Drug Review: a NICE start for Canada? Health policy (Amsterdam, Netherlands)Health Policy. 2006;77(3):339-351.
Morgan SG, McMahon M, Lam JM, Mooney D, Raymond CB. Canadian Rx Atlas, 1st edition. UBC Centre for Health Services and Policy Research; 2005.